Press "Enter" to skip to content

New patent expiration for Recordati Rare drug NEOPROFEN

2
Copyright © DrugPatentWatch. Originally published at New patent expiration for Recordati Rare drug NEOPROFEN

Annual Drug Patent Expirations for NEOPROFEN
Annual Drug Patent Expirations for NEOPROFEN

Neoprofen is a drug marketed by Recordati Rare and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug and one Paragraph IV challenge.

This drug has twelve patent family members in six countries.

The generic ingredient in NEOPROFEN is ibuprofen lysine. Two suppliers are listed for this compound. Additional details are available on the ibuprofen lysine profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Recordati Rare drug NEOPROFEN
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!